Traces of SARS-CoV-2 RNA in Peripheral Blood Cells of Patients with COVID-19
This article has been Reviewed by the following groups
Discuss this preprint
Start a discussion What are Sciety discussions?Listed in
- Evaluated articles (ScreenIT)
Abstract
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the third virus that caused coronavirus-related outbreaks over the past 20 years. The outbreak was first reported in December 2019 in Wuhan, China, but rapidly progressed into a pandemic of an unprecedented scale since the 1918 flu pandemic. Besides respiratory complications in patients with COVID-19, clinical characterization of severe infection cases showed several other comorbidities, including multiple organ failure, and septic shock. To better understand the systemic pathogenesis of COVID-19, we interrogated the virus's presence in the peripheral blood cells, which might provide a form of trafficking or hiding to the virus. By analyzing >2 billion sequence reads of high-throughput transcriptome sequence data from 180 samples of patients with active SARS-CoV-2 infection or healthy controls collected from 6 studies, we found evidence of traces of SARS-CoV-2 RNA in peripheral blood mononuclear cells in two samples from two independent studies. In contrast, the viral RNA was abundant in bronchoalveolar lavage specimens from the same patients. We also devised a “viral spike-to-actin” RNA normalization as a metric to compare across various samples and minimize errors caused by intersample variability in total human RNA abundance. Our observation suggests immune presentation and discounts the possibility of extensive viral infection of lymphocytes or monocytes.
Article activity feed
-
-
SciScore for 10.1101/2020.05.10.20097055: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Institutional Review Board Statement not detected. Randomization not detected. Blinding not detected. Power Analysis not detected. Sex as a biological variable not detected. Table 2: Resources
Software and Algorithms Sentences Resources Comparison of RNA Abundance and Gene Expression Profiles: Filtered FASTQ sequences were searched with blastx (Altschul et al. 1990) against the RefSeq protein database (O’Leary et al. 2016) (release 99) using DIAMOND (Buchfink, Xie, and Huson 2015) with an e-value cutoff < 1e-10. Gene Expression Profilessuggested: Noneblastxsuggested: (BLASTX, RRID:SCR_001653)RefSeqsuggested: (RefSeq, RRID:SCR_003496)DIAMONDsuggested: (DIAMOND, RRID:SCR_009457)For functional annotation, the … SciScore for 10.1101/2020.05.10.20097055: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Institutional Review Board Statement not detected. Randomization not detected. Blinding not detected. Power Analysis not detected. Sex as a biological variable not detected. Table 2: Resources
Software and Algorithms Sentences Resources Comparison of RNA Abundance and Gene Expression Profiles: Filtered FASTQ sequences were searched with blastx (Altschul et al. 1990) against the RefSeq protein database (O’Leary et al. 2016) (release 99) using DIAMOND (Buchfink, Xie, and Huson 2015) with an e-value cutoff < 1e-10. Gene Expression Profilessuggested: Noneblastxsuggested: (BLASTX, RRID:SCR_001653)RefSeqsuggested: (RefSeq, RRID:SCR_003496)DIAMONDsuggested: (DIAMOND, RRID:SCR_009457)For functional annotation, the matching RefSeq proteins were annotated by Pfam (Finn et al. 2014) using HMMER (Eddy 2011). Pfamsuggested: (Pfam, RRID:SCR_004726)HMMERsuggested: (Hmmer, RRID:SCR_005305)Identified SARS-CoV-2 matching sequences were manually inspected and searched against NCBI “nt” by BLAST (blastn) for verification (Altschul et al. 1990). BLASTsuggested: (BLASTX, RRID:SCR_001653)Results from OddPub: We did not detect open data. We also did not detect open code. Researchers are encouraged to share open data when possible (see Nature blog).
Results from LimitationRecognizer: An explicit section about the limitations of the techniques employed in this study was not found. We encourage authors to address study limitations.Results from TrialIdentifier: No clinical trial numbers were referenced.
Results from Barzooka: We did not find any issues relating to the usage of bar graphs.
Results from JetFighter: We did not find any issues relating to colormaps.
Results from rtransparent:- Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
- Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
- No protocol registration statement was detected.
-
